Therefore, we reviewed the history of TNF-α antibodies in drug development for heart failure and RA as a reference to identify the reason for such a warning in the recommendations and its applicability to ICI-induced myocarditis,. This evidence concerns the gene TNF and rheumatoid arthritis.